Noble Life Sciences CEO on Biotech Business Climate

Posted Date: 
October 13, 2011

Kenneth Carter, President & CEO of Noble Life Sciences, Inc addresses the Economic Development Committee.

Kenneth Carter, President & CEO of Noble Life Sciences, Inc., spoke to the Economic Development Committee about the County and State entrepreneurial environment. Stewart Edelstein, Executive Director of the Universities at Shady Grove and committee Vice-Chair, introduced Carter and led the discussion in committee.

Carter has been labeled as a “serial entrepreneur” by several regional publications. In addition to Noble Life Sciences, Inc., Carter has also founded Black Rock BioCapital, Avalon Pharmaceuticals, and International Genetics Associates, Inc. Between Noble Life Sciences and Black Rock BioCapital, Carter plans to fund five businesses by the end of 2011.

In speaking to the Economic Development Committee, Carter focused his remarks on the business climate in Montgomery County and with the State of Maryland. Carter praised the State legislature for passing the InvestMaryland Bill, which the Chamber supported in the 2011 session. He pointed out that Maryland is a leader in investment in biotechnology nationally, but still falls behind the cities of Boston and San Francisco, who have set a high standard for investment in biotechnology. North Carolina and San Diego have also invested resources into the biotechnology sector.

Carter talked about Maryland’s highly talented pool for the industry through the efforts of the National Institutes of Health (NIH), the University of Maryland, and Johns Hopkins University. He recommended changes to certain Federal regulations that would allow for additional investment and collaboration between the public and private sector.

Carter is encouraging the state to look long term on investment in bioscience and to establish a consistent business climate in Maryland. 


Tagged in:

MCCC Strategic Partners